AstraZeneca does AI deal with insitro; inVIOs' Phase 1 success in solid tumors

Plus news about ImmunityBio, Modus Therapeutics and Hyperway Pharmaceutical. AstraZeneca strikes AI drug discovery deal with insitro: The pharma giant will pay the California-based company $40 million upfront. In return, insitro's ...

endpoints.news ·1h ago

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Also reported by 3 other outlets

AstraZeneca strikes $40 million AI drug discovery deal with Insitro business-standard.com
AstraZeneca inks AI drug discovery deal worth up to $1.5B with insitro seekingalpha.com
AstraZeneca strikes $40 million AI drug discovery deal with insitro channelnewsasia.com

Read the original at endpoints.news →

More in AI

Amazon debuts two new AI wearable devices that can listen to conversations and help you shop

Amazon.com Inc. today debuted two new wearable, artificial intelligence-enabled devices aimed at making everyday life simpler by listening to conversations and helping users remember what matters.

1h ago ·siliconangle.com

Analysis-Market selloff, rising rates test AI data centre deal boom

1h ago ·investing.com

IPX Exchange - The Agentic OS & Tokenized Exchange for IP Closes $4M Seed Round at a $125M Valuation

1h ago ·investing.com

Hubtel CEO calls for national data-sharing framework to boost AI development

The Chief Executive Officer of Hubtel, Alex Bram, has called for a national data-sharing framework that encourages companies to preserve and make data available under appropriate arrangements to support the development of artificial intelligence (AI) in Ghana.

1h ago ·myjoyonline.com

Hubtel CEO calls for national data-sharing framework to boost AI development

1h ago ·myjoyonline.com

AMA releases governance framework for agentic AI in healthcare

Industry groups have worked to release guidance on artificial intelligence-backed agents in the absence of federal regulation.

1h ago ·healthcaredive.com